# A Study of LY3971297 in Healthy Participants

> **NCT06148272** · PHASE1 · RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 225 (estimated)

## Conditions studied

- Healthy
- Obesity
- Hypertension

## Interventions

- **DRUG:** LY3971297
- **DRUG:** Placebo
- **DRUG:** LY3971297 IV

## Key facts

- **NCT ID:** NCT06148272
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-07
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 225 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06148272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06148272, "A Study of LY3971297 in Healthy Participants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06148272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*